Literature DB >> 19746220

Glucose transporter-1 expression in squamous cell carcinoma of the tongue.

Yoon Seok Choi1, Seok Jin Kim, Dae Sik Kim, Seh Jong Park, Yong Park, Hye Jin Shin, Kwang-Yoon Jung, Seung-Kuk Baek, Bong Kyung Shin, Jung Woo Choi, Byung Soo Kim, Sang Won Shin, Yeul Hong Kim, Jun Suk Kim.   

Abstract

PURPOSE: Tumor cells are known to express hypoxia-related proteins such as glucose transporter-1 (Glut-1). These hypoxia-induced changes may allow tumor cells to survive under sustained hypoxic microenvironments, and the surviving tumor cell under hypoxia may develop a more aggressive phenotype and so result in a poor prognosis.
MATERIALS AND METHODS: The Glut-1 expression was analyzed by immunohistochemistry, and its association with the prognosis was assessed in 60 patients with squamous cell carcinoma of the tongue.
RESULTS: The Glut-1 expression was diffuse with a membranous pattern, and the median percentage of Glut-1 positive tumor cells was 60% (range: 0.0 approximately 90.0%). A high Glut-1 expression (the percentage of positive tumor cells >or= the median value, 60%) was associated with the location of primary lesion, lymph node metastasis status and disease stage (p<0.05). The expression of Glut-1 was correlated with the Ki-67 expression (r=0.406, p=0.001). Microvessel density, as represented by CD31 staining, was also correlated with the Glut-1 expression although its significance is weak (r=0.267, p=0.039). On the univariate analysis, the group with a high Glut-1 expression showed poorer overall survival than the group with a low Glut-1 expression (p<0.05). However, the Glut-1 expression failed to show any independent prognostic significance on the multivariate analysis.
CONCLUSION: The expression of Glut-1 may be useful for predicting the prognosis and determining the treatment strategy for the management of squamous cell carcinoma of the tongue.

Entities:  

Keywords:  Glucose transporter-1; Squamous cell carcinoma; Tongue; Tumor hypoxia

Year:  2007        PMID: 19746220      PMCID: PMC2739325          DOI: 10.4143/crt.2007.39.3.109

Source DB:  PubMed          Journal:  Cancer Res Treat        ISSN: 1598-2998            Impact factor:   4.679


  14 in total

1.  Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial.

Authors:  Michael I Koukourakis; Søren M Bentzen; Alexandra Giatromanolaki; George D Wilson; Frances M Daley; Michele I Saunders; Stanley Dische; Efthimios Sivridis; Adrian L Harris
Journal:  J Clin Oncol       Date:  2006-01-17       Impact factor: 44.544

Review 2.  Hypoxia--a key regulatory factor in tumour growth.

Authors:  Adrian L Harris
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

3.  Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival.

Authors:  T Kawamura; T Kusakabe; T Sugino; K Watanabe; T Fukuda; A Nashimoto; K Honma; T Suzuki
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

4.  Carbonic anhydrase IX in early-stage non-small cell lung cancer.

Authors:  Seok Jin Kim; Zahid N Rabbani; Robin T Vollmer; Ernst-Gilbert Schreiber; Egbert Oosterwijk; Mark W Dewhirst; Zeljko Vujaskovic; Michael J Kelley
Journal:  Clin Cancer Res       Date:  2004-12-01       Impact factor: 12.531

5.  Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy.

Authors:  M I Koukourakis; A Giatromanolaki; E Sivridis; K Simopoulos; J Pastorek; C C Wykoff; K C Gatter; A L Harris
Journal:  Clin Cancer Res       Date:  2001-11       Impact factor: 12.531

6.  Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.

Authors:  Daniel E B Swinson; J Louise Jones; Donna Richardson; Charles Wykoff; Helen Turley; Jaromir Pastorek; Nick Taub; Adrian L Harris; Kenneth J O'Byrne
Journal:  J Clin Oncol       Date:  2003-02-01       Impact factor: 44.544

7.  Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.

Authors:  Martin Kunkel; Torsten E Reichert; Peter Benz; Hans-Anton Lehr; Jong-Hyeon Jeong; Samuel Wieand; Peter Bartenstein; Wilfried Wagner; Theresa L Whiteside
Journal:  Cancer       Date:  2003-02-15       Impact factor: 6.860

8.  Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas.

Authors:  Anna S E Ljungkvist; Johan Bussink; Paulus F J W Rijken; Johannes H A M Kaanders; Albert J van der Kogel; Juliana Denekamp
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-09-01       Impact factor: 7.038

9.  Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Translational Research Fund studies.

Authors:  R J Oliver; R T M Woodwards; P Sloan; N S Thakker; I J Stratford; R E Airley
Journal:  Eur J Cancer       Date:  2004-03       Impact factor: 9.162

10.  GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.

Authors:  Rachel E Airley; Juliette Loncaster; James A Raleigh; Adrian L Harris; Susan E Davidson; Robert D Hunter; Catharine M L West; Ian J Stratford
Journal:  Int J Cancer       Date:  2003-03-10       Impact factor: 7.396

View more
  6 in total

1.  Expression of GLUT-1 in oral squamous cell carcinoma in tobacco and non-tobacco users.

Authors:  Neha Azad; Malti Kumari Maurya; Meenakshi Kar; Madhu Mati Goel; Ajay Kumar Singh; Mala Sagar; Divya Mehrotra; Vijay Kumar
Journal:  J Oral Biol Craniofac Res       Date:  2016-01-08

2.  Hypoxia-related protein expression and its clinicopathologic implication in carcinoma of unknown primary.

Authors:  Ja Seung Koo; Haeryoung Kim
Journal:  Tumour Biol       Date:  2011-05-20

3.  Prognostic impacts of hypoxic markers in soft tissue sarcoma.

Authors:  Eivind Smeland; Thomas K Kilvaer; Sveinung Sorbye; Andrej Valkov; Sigve Andersen; Roy M Bremnes; Lill-Tove Busund; Tom Donnem
Journal:  Sarcoma       Date:  2012-02-20

4.  Can Increased Metabolic Status be a Grading Tool for Oral Squamous Cell Carcinoma? A Glucose Transporter 1 Immunoexpression Study.

Authors:  Abikshyeet Panda; Alokenath Bandyopadhyay; Gouse Mohiddin; Malvika Raghuvanshi; Sanjay Kumar Sahoo; Lipsa Bhuyan
Journal:  Niger J Surg       Date:  2019 Jul-Dec

5.  Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis.

Authors:  Yanting Wang; Yuanyuan Li; Laibo Jiang; Xianyue Ren; Bin Cheng; Juan Xia
Journal:  Aging (Albany NY)       Date:  2021-02-26       Impact factor: 5.682

6.  GLUT1/3/4 as novel biomarkers for the prognosis of human breast cancer.

Authors:  Kai Zeng; Gaoda Ju; Hao Wang; Jiangsheng Huang
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.